Pacult Mark A, Karsy Michael, Evans James J, Kim Won, Pacione Donato R, Gardner Paul A, Fernandez-Miranda Juan C, Zada Gabriel, Rennert Robert C, Silverstein Julie M, Kim Albert H, Kshettry Varun R, Chicoine Michael R, Little Andrew S
Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States.
Department of Neurosurgery, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States.
J Neurol Surg B Skull Base. 2024 Aug 20;86(5):562-569. doi: 10.1055/s-0044-1789193. eCollection 2025 Oct.
Patients undergoing surgery for Cushing's disease may be more likely to be readmitted to the hospital than other patients with pituitary disorders. We investigated rates, causes, and predictors of unplanned readmission following transsphenoidal surgery for Cushing's disease to identify areas for clinical, financial, and administrative improvements.
Retrospective cohort study.
Academic pituitary centers in the United States participating in a multicenter surgical outcome registry.
Five hundred and nineteen patients underwent transsphenoidal surgery for treatment of Cushing's disease by 26 surgeons at nine participating institutions from 2003 to 2023.
Unplanned 90-day readmission rates and causes of readmission.
Unplanned readmissions occurred in 57/519 patients (11.0%), with hyponatremia in 12/57 (21%), cerebrospinal fluid leak evaluation in 8/57 (14%), epistaxis in 6/57 (10%), deep vein thrombosis in 4/57 (7%), syncope in 3/57 (5%), and headache in 3/57 (5%). Factors including no tumor on initial magnetic resonance imaging, return to the operating room during the index admission, lack of early remission, and inpatient complications were associated with a greater probability of readmission on univariate analysis. However, none remained predictive on multivariate analysis.
Our results show that readmission rates after transsphenoidal surgery for Cushing's disease are comparable to previously reported rates for all pituitary-related disorders, with the most common reason being hyponatremia. High-impact clinical protocols focused on preventing delayed hyponatremia may reduce the risk of readmission. Failure to identify significant predictors of readmission, even in this large clinical dataset, underscores the challenge of identifying high-risk clinical cohorts.
与其他垂体疾病患者相比,库欣病患者接受手术后再次入院的可能性可能更高。我们调查了库欣病经蝶窦手术后计划外再入院的发生率、原因及预测因素,以确定临床、财务和管理方面可改进的领域。
回顾性队列研究。
美国参与多中心手术结果登记的学术性垂体中心。
2003年至2023年期间,来自9个参与机构的26名外科医生为519例患者进行了经蝶窦手术治疗库欣病。
计划外90天再入院率及再入院原因。
519例患者中有57例(11.0%)出现计划外再入院,其中低钠血症12例(21%),脑脊液漏评估8例(14%),鼻出血6例(10%),深静脉血栓形成4例(7%),晕厥3例(5%),头痛3例(5%)。单因素分析显示,包括初始磁共振成像未发现肿瘤、在首次住院期间返回手术室、缺乏早期缓解以及住院并发症等因素与再入院概率增加相关。然而,多因素分析中无一因素仍具有预测性。
我们的结果表明,库欣病经蝶窦手术后的再入院率与先前报道的所有垂体相关疾病的再入院率相当,最常见的原因是低钠血症。专注于预防迟发性低钠血症的高影响力临床方案可能会降低再入院风险。即使在这个大型临床数据集中,未能识别出再入院的显著预测因素,凸显了识别高危临床队列的挑战。